Antje van Lessen - Concepedia

Author

Antje van Lessen

Charité - Universitätsmedizin Berlin

Also Known As

A van Lessen, A. van Lessen, Antje Van Lessen, Antje van Lessen

Publications

443

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Freie Universität Berlin Vivantes Klinikum

About

Antje van Lessen is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	134
2	Immunology	5	5	111
3	Cell Biology	2	2	36
4	Molecular Biology	2	2	23
5	Allergy	1	1	39

Antje van Lessen

Publications

387

Citations

H-Index

Page 1

	Year	Citations
Quantitative fluorescence flow cytometry: A comparison of the three techniques for direct and indirect immunofluorescence Stefan Serke, Antje van Lessen, D. Huhn Cytometry	1998	76
Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen Ulrike Schneider, Antje van Lessen, D. Huhn, British Journal of Haematology	1997	69
Vaccination with autologous non‐irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia Jörg Westermann, Joachim Kopp, Antje van Lessen, British Journal of Haematology	2007	40
Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma Stefan Serke, Antje van Lessen, Michael Hummel, Cytometry Tcr Gamma ChainCd4+ TLymphoid NeoplasiaAllergyAutoimmune Disease	2000	39
Peripheral blood sCD3<sup>−</sup>CD4<sup>+</sup>T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma Anju Singh, Richard Schabath, Richard Ratei, Hematological Oncology	2013	34
Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer Anne Flörcken, Joachim Kopp, Antje van Lessen, Human Vaccines & Immunotherapeutics	2013	34
Up-regulated<i>MSI2</i>is associated with more aggressive chronic myeloid leukemia Jaspal Kaeda, Frauke Ringel, Christian Oberender, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyTumor BiologyChronic Myeloid LeukemiaSystems BiologyMusashi 2	2014	24
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study Jörg Westermann, Anne Flörcken, Gerald Willimsky, Gene Therapy Tumor ImmunologyCancer ImmunosurveillanceClinical Phase-i StudyMedicineImmunology	2010	18
Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma Anne Flörcken, Anna Takvorian, Antje van Lessen, Anti-Cancer Drugs Cancer ImmunosurveillanceGenitourinary CancerMedicineImmunologyMetastatic Rcc	2011	18
Binding of mitogenic plant lectins to human lymphocytes Stefan Serke, Andreas Neubauer, Antje van Lessen Journal of Immunological Methods Mitogenic PlantImmunologyMedicineCell BiologyPlant Cytology	1989	12

Page 1